Zobrazeno 1 - 10
of 24
pro vyhledávání: ''
Autor:
Ryo Tanaka, Toshifumi Yamaguchi, Narikazu Boku, Kei Hosoda, Kazuhiro Nishikawa, Hitoshi Katai, Manabu Ohashi, Takahiro Kinoshita, Naoki Kakihara, Tatsuya Yamada, Hisayuki Matsushita, Atsuo Takashima, Masaki Aizawa, Kengo Nagashima, Masanori Terashima, Shusuke Haruta, Taroh Satoh, Yasuhiro Yuasa, Gen Yunome, Koshiro Ishiyama, Takeo Fukagawa
Publikováno v:
Gastric Cancer. 24:701-709
Gastric cancer (GC) patients with peritoneal metastasis are defined as stage IV in the Japanese classification of GC. For patients with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) and/or localized peritoneal metastasis
Autor:
G.A.P. Nieuwenhuijzen, L. Heuthorst, I. Mokadem, N. Haj Mohammad, J. de Vos-Geelen, M. van Putten, Willemieke P M Dijksterhuis, H.W.M. van Laarhoven, Rob H.A. Verhoeven
Publikováno v:
Gastric Cancer, 22(6), 1263-1273. Springer, Cham
Gastric Cancer, 22(6), 1263. Springer Japan
Gastric cancer, 22(6), 1263-1273. Springer Japan
Gastric Cancer, 22, 6, pp. 1263-1273
Gastric Cancer, 22, 1263-1273
Gastric Cancer
Gastric Cancer, 22(6), 1263. Springer Japan
Gastric cancer, 22(6), 1263-1273. Springer Japan
Gastric Cancer, 22, 6, pp. 1263-1273
Gastric Cancer, 22, 1263-1273
Gastric Cancer
Background In most western European countries perioperative chemotherapy is a part of standard curative treatment for gastric cancer. Nevertheless, recurrence rates remain high after multimodality treatment. This study examines patterns of recurrence
Autor:
Ryo Takahashi, Naoki Hiki, Masato Nagino, Manabu Ohashi, Kensei Yamaguchi, Yosuke Kano, Takeshi Sano, Satoshi Ida, Koshi Kumagai, Souya Nunobe, Keisho Chin
Publikováno v:
Gastric Cancer. 22:1256-1262
Adjuvant S-1 monotherapy prolongs the survival of patients with pathological stage II or III gastric cancer undergoing D2 gastrectomy. This therapeutic regimen is standard in Japan. Unfortunately, some patients who undergo this treatment suffer from
Autor:
Kiyokazu Nakajima, Yasuhiro Miyazaki, Makoto Yamasaki, Jun-ichiro Ikeda, Masaki Mori, Tadayoshi Hashimoto, Yukinori Kurokawa, Koji Tanaka, Tsuyoshi Takahashi, Tomoki Makino, Yuichiro Doki
Publikováno v:
Gastric Cancer. 22:785-792
Microsatellite instability (MSI) and programmed death-ligand 1 (PD-L1) are candidate predictors for the response to immune checkpoint inhibitors, and may predict chemotherapy sensitivity. We investigated the simultaneous expression of mutL homolog 1
Autor:
Masaki Endo, Noriyuki Uesugi, Risaburo Akasaka, Keisuke Kawasaki, Makoto Eizuka, Tamotsu Sugai, Shunichi Yanai, Yosuke Toya, Takayuki Matsumoto, Keisuke Koeda, Shotaro Nakamura, Yasuko Fujita, Kazuyuki Ishida
Publikováno v:
Gastric Cancer. 22:838-844
Little is known about the long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection (ESD) in elderly patients with early gastric cancer. Clinicopathological findings and long-term outcomes were evaluated in 87 patie
Autor:
Kojiro Eto, Daisuke Takahari, Keisho Chin, Naoki Hiki, Yasuo Tsuda, Souya Nunobe, Yoshiaki Shoji, Kensei Yamaguchi, Manabu Ohashi, Itaru Yasufuku, Koshi Kumagai, Takeshi Sano, Yosuke Kano, Satoshi Ida
Publikováno v:
Gastric Cancer. 21:1024-1030
One-year adjuvant S-1 monotherapy following D2 gastrectomy has been the Japanese treatment standard for pathological stage II or III gastric cancer since the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (ACTS-GC) was concluded in 2007. Trial
Autor:
Jin-Ho Kim, Kee Don Choi, Ho June Song, Jeong Hoon Lee, Seong Hwan Park, Hwoon-Yong Jung, Do Hoon Kim, Kee Wook Jung, Eun Jeong Gong, Ji Yong Ahn, Gin Hyug Lee, Hee Kyong Na, Sunpyo Lee, Seung-Mo Hong
Publikováno v:
Gastric Cancer. 20:843-852
Although extragastric recurrence after endoscopic resection of early gastric cancer is rare, it is important because of its potentially fatal outcomes. We investigated the patterns of extragastric recurrence after endoscopic resection and evaluated t
Autor:
Takeshi Sano, Mitsuru Sasako, Hiroharu Yamashita, Hiroyasu Makuuchi, Yasuyuki Seto, Nobutoshi Ando
Publikováno v:
Gastric Cancer. 20:69-83
Esophagogastric junction (EGJ) carcinoma has attracted considerable attention because of the marked increase in its incidence globally. However, the optimal extent of esophagogastric resection for this tumor entity remains highly controversial. This
Autor:
Joongyub Lee, Do-Youn Oh, Sae-Won Han, Tae-You Kim, Ah Rong Nam, Yung-Jue Bang, Ju Hee Bang, Chan Young Ock, Tae Yong Kim, Seock-Ah Im, Kyung-Hun Lee
Publikováno v:
Gastric Cancer. 20:254-262
The neutrophil–lymphocyte ratio (NLR) is associated with a poor prognosis in many cancers but the biological mechanisms involved are unknown. Since cytokines and angiogenic factors (CAFs) are reflected by various immune responses, we analyzed the a
Autor:
Alain Duhamel, Cécile Brigand, Antoine Hamy, Thibault Voron, Mathieu Messager, Jean-Yves Mabrut, Christophe Mariette, Jérémie H. Lefevre, Bernard Meunier, François Paye, Diane Goéré, Olivier Glehen
Publikováno v:
Gastric Cancer. 19:1027-1040
The prognosis and chemoresistance of signet-ring cell (SRC) gastric adenocarcinoma have been reported and debated, and the utility of perioperative chemotherapy for such a tumor has been questioned . This study was performed to assess the impact of t